本页面由Tiger Trade Technology Pte. Ltd.提供服务

Caris Life Sciences, Inc.

27.94
+0.08000.29%
盘后27.970.0300+0.11%19:15 EST
成交量:416.49万
成交额:1.17亿
市值:78.83亿
市盈率:-4.31
高:28.44
开:27.86
低:27.75
收:27.86
52周最高:42.50
52周最低:22.86
股本:2.82亿
流通股本:9,191.75万
量比:1.91
换手率:4.53%
股息:- -
股息率:- -
每股收益(TTM):-6.4846
每股收益(LYR):-10.6561
净资产收益率:--
总资产收益率:-42.48%
市净率:16.48
市盈率(LYR):-2.62

数据加载中...

2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report
2025/10/30

重要事件披露

Form 8-K - Current report
2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report
2025/06/20

重要事件披露

Form 8-K - Current report
2025/06/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/16

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/06/14

SEC问询函

Form CORRESP - Correspondence
2025/06/14

SEC问询函

Form CORRESP - Correspondence
2025/06/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/05/24

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/21

重要事件披露

8-K - Current report
2021/06/08

重要事件披露

8-K - Current report
2021/05/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/30

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/29

重要事件披露

8-K - Current report